Page 37

Junio 2016

ARTÍCULOS DE INVESTIGACIÓN 715 Referencias 1. Robertson WG, Peacock M, Baker M, Marshall DH, Pearlman B, Speed R. Studies on the prevalence and epidemiology of urinary stone disease in men in Leeds. Br J Urol 1983; 55: 595-8. 2. Andersen DA. Environmental factors in the aetiology of urolithiasis. In: Urinary Calculi; ed. Cifuentes Delatte L, Rapado A, Hodgkinson A. Pp. 130-144. 1973, Karger Publishers. Basel, Switzerland. 3. Fink H, Akornor J, Garimella P, MacDonald R, Cutting A, et al. Diet, Fluid, or Supplements for Secondary Prevention of Nephrolithiasis: A Systematic Review and Meta-Analysis of Randomized Trials. Eur Urol 2009; 56: 72-80. 4. Coe FL, Worcester EM. Calcium kidney stones. N Engl J Med 2010; 363: 954-63. 5. Robertson WG, Peacock M, Hodgkinson A. Dietary Changes and the incidence of urinary calculi in the U.K. between 1958 and 1976. J Chronic Dis 1979; 32: 469-76. 6. Andersen DA. Historical and geographical differences in the pattern of incidence of urinary stones considered in relation to possible aetiological factors. En: Proc Renal Stone. London, Churchill 1969; 7-31. 7. Curhan GC, Willett WC, Rimm EB, Stauffer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidnay stones. N Engl J Med 1993; 328: 833-8. 8. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002; 346 (2): 77-84. 9. Ossandón E, Storme O, Ledesma R, Marchant F, Palma C. Resultados del estudio metabólico en 54 pacientes con urolitiasis de alto riesgo de recurrencia. Act Urol Esp 2009; 33: 429-32. 10. Sur RL, Preminger GM. Medical Treatment: Worthwhile and When? EAU Update Series 2005; 3: 10-6. 11. Van Drongelen J, Kiemeney LA, Debruyne FM, de la Rosette JJ. Impact of urometabolic evaluation on prevention of urolithiasis: a retrospective study. Urology 1998; 52: 384-91. 12. Siener R, Glatz S, Nicolay C, Hesse A. Prospective Study on the Efficacy of a Selective Treatment and Risk Factors for Relapse in Recurrent Calcium Oxalate Stone Patients. Eur Urol 2003; 44: 467-74. 13. Norman RW, Bath SS, Robertson WG, Peacock M. When should patients with symptomatic stone disease be evaluated metabolically? J Urol 1984; 132: 1137-9. 14. Robertson WG. Medical management of urinary stone disease. European Urology Update Series 1998; 7: 139- 44. 15. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996; 155: 839-43. 16. Curham GC, Willett WC, Rimm ED, Spiegelman D,Stauffer MJ. Prospective study of beverage and the risk of kidney stones. Am J epidemiol 1996; 143: 240-7. 17. Spernat D, Kourambos J. Urolithiasis. Medical therapies. BJU International Australia and New Zealand Supplement 2011; 108, (supplement 2): 9-13. 18. Escribano J, Balaguer A, Pagone F, Feliu A, Roque I, Figuls M. Pharmacological intervntions for preventing complication in idiopathic hypercalciuria. Cochrane Database Syst Rev 2009; 1: CD004754. 19. Fabris A, Lupo A, Bernich P, et al. Long term treatment with potassium citrate and renal stones in medullary sponge kidney. Clin J Am Soc Nephrol 2010; 5: 1663-8. 20. Ettinger B, Tang A, Citron JT, Livermore B, Williams T, Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986; 315: 1386-9. Profilaxis secundaria en urolitiasis - E. Ossandón et al Rev Med Chile 2016; 144: 710-715


Junio 2016
To see the actual publication please follow the link above